Dr. Hui Zhao
Research AssistantXi’an International Medical Center Hospital, Xitai Road Xi’an, Shaanxi, China
Highest Degree
M.B.B.S in Life Science and Medicine from Northwest University, China
Share this Profile
Xi’an International Medical Center Hospital, Xitai Road Xi’an, Shaanxi, China
Area of Interest:
Biomedical Sciences
100%
Natural Products
62%
Life Science and Medicine
90%
Lung Cancer
75%
Lipid Disorders
55%
Research Publications in Numbers
Books
0
0
Chapters
0
0
Articles
9
9
Abstracts
0
0
Selected Publications
- Zhao, H., S.X. Ma, Y.Q. Shang, H.Q. Zhang and W. Su, 2019. microRNAs in chronic kidney disease. Clin. Chim. Acta, 491: 59-65.
CrossRef | Direct Link | - Zhao, H., L. Chen, T. Yang, Y.L. Feng and N.D. Vaziri et al., 2019. Aryl hydrocarbon receptor activation mediates kidney disease and renal cell carcinoma. J. Transl. Med., Vol. 17. 10.1186/s12967-019-2054-5.
CrossRef | Direct Link | - Yang, T., Y.Y. Chen, J.R. Liu, H. Zhao, N.D. Vaziri, Y. Guo and Y.Y. Zhao, 2019. Natural products against renin-angiotensin system for antifibrosis therapy. Eur. J. Med. Chem., 179: 623-633.
CrossRef | Direct Link | - Liu, D., L. Chen, H. Zhao, N.D. Vaziri, S.C. Ma and Y.Y. Zhao, 2019. Small molecules from natural products targeting the Wnt/u03b2-catenin pathway as a therapeutic strategy. Biomed. Pharmacother., Vol. 117. 10.1016/j.biopha.2019.108990.
CrossRef | Direct Link | - Chen, D.Q., G. Cao, H. Zhao, L. Chen and T. Yang et al., 2019. Combined melatonin and poricoic acid A inhibits renal fibrosis through modulating the interaction of Smad3 and β-catenin pathway in AKI-to-CKD continuum. Ther. Adv. Chronic Dis., Vol. 10. 10.1177/2040622319869116.
CrossRef | Direct Link | - Wang, M., D.Q. Chen, L. Chen, G. Cao and H. Zhao et al., 2018. Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis. Br. J. Pharmacol., 175: 2689-2708.
CrossRef | Direct Link | - Chen, L., T. Yang, D.W. Lu, H. Zhao and Y.L. Feng et al., 2018. Central role of dysregulation of TGF-β/Smad in CKD progression and potential targets of its treatment. Biomed. Pharmacother., 101: 670-681.
CrossRef | Direct Link | - Wang, M., D.Q. Chen, M.C. Wang, H. Chen and L. Chen et al., 2017. Poricoic acid ZA, a novel RAS inhibitor, attenuates tubulo-interstitial fibrosis and podocyte injury by inhibiting TGF-β/Smad signaling pathway. Phytomedicine, 36: 243-253.
CrossRef | Direct Link |